Light Can Turn Brain Cells On & Off. An IISc Scientist Is Using It to Understand Pain

Optogenetics is a technique for controlling specific nerve cells with light. It matters because scientists can test exactly what a particular group of neurons does, instead of affecting many cells at once. This precision helps reveal how the brain creates sensations and behaviors.

The method began with channelrhodopsin, a light-sensitive protein discovered in a single-celled alga by Peter Hegemann and Georg Nagel. Karl Deisseroth later developed the discovery into a tool for controlling neurons. When light reaches neurons equipped with such proteins, their activity can be changed, allowing researchers to switch selected cells on or off.

Dr Arnab Barik uses optogenetics to map and manipulate circuits involved in pain, itch, and stress. His team has tested how changing particular brain cells affects scratching and pain processing in mice. The work may support more precise treatments, though the article presents broader medical use as an area researchers are still exploring.

Channelrhodopsin is a light-sensitive protein discovered in a single-celled alga. Its importance is that it responds to light and can be used as a biological control switch. Scientists adapted that property to ask highly specific questions about brain activity.

When channelrhodopsin is placed in selected neurons, shining light on those cells changes their electrical state. That can make the neurons active, effectively switching them on. Related light-sensitive tools can reduce activity, allowing researchers to switch selected cells off. The article explains the result as precise control over nerve cells, rather than a general effect across the brain.

Peter Hegemann and Georg Nagel discovered channelrhodopsin, and Karl Deisseroth later turned the discovery into a neuron-control method. Barik’s laboratory uses this approach to manipulate pain and itch circuits in mice. Its value is experimental precision, while treatment applications remain an area researchers are exploring.

The article presents pain as the work of connected circuits, not a single small brain area. Pain begins with an injury, but the brain also processes and shapes the experience. This matters because the same physical signal can be influenced by stress and by the brain’s emotional response.

In mice, Barik’s team mapped a circuit connecting parts of the brain and spinal cord. They found that stress can alter activity in this circuit, changing how pain is processed. Another study identified a brain pathway involved in pain and its emotional impact after chemotherapy made harmless cold painful. These findings show that pain involves linked regions and pathways.

The article does not measure the network’s size or list every region involved. It does show that researchers are using optogenetics to map and manipulate these connections. Understanding the network could help develop more precise treatments for chronic pain and related conditions.

Barik’s experiments show that stress can reshape activity in brain circuits linked to pain and itch. This matters because pain and itch are not fixed readouts of injury or irritation. The brain’s state can influence how strongly these protective sensations are processed and expressed.

His team mapped a circuit connecting parts of the brain and spinal cord and found that stress altered its activity, changing pain processing. In separate work, the laboratory identified brain cells that became active during stress. Activating those cells reduced scratching in mice. Switching them off brought the scratching back, linking their activity to itch behavior.

These results came from mouse experiments, so the article does not claim they directly explain human symptoms. They do show how optogenetics can test cause and effect in specific circuits. The findings may guide more precise approaches to chronic pain and itch, which can become debilitating.

When pain or itch continues after its original trigger, it can become chronic rather than protective. The article says these sensations normally protect us, but chronic pain and itch can be debilitating. Their persistence shows that the experience depends not only on an injury or irritant, but also on ongoing brain processing.

The article gives two examples. After chemotherapy, harmless cold became painful in mice, and researchers identified a brain pathway linked to both the pain and its emotional impact. In another study, stress-related brain cells influenced scratching: activating them reduced scratching, while switching them off restored it. These findings connect symptoms to specific neural activity.

The work is still research in mice, not a stated treatment for people. By mapping and manipulating these circuits, Barik’s team hopes to clarify how chronic symptoms persist. That knowledge could help researchers develop more precise ways to treat chronic pain and itch.

Optogenetics differs from drugs and electrical stimulation mainly in precision. Drugs can influence many cells and pathways throughout the body or brain, while electrical stimulation can affect neurons near an electrode. Optogenetics is designed to control selected nerve cells with light, letting researchers ask what one defined group does.

Its mechanism is also distinctive. Scientists use light-sensitive proteins, such as channelrhodopsin, to make chosen neurons respond to light. They can then activate or suppress those cells and observe changes in pain, itch, or behavior. This direct testing helps separate cause from correlation in brain-circuit research.

The article focuses on optogenetics as a research tool, especially in mice. It says researchers are exploring uses beyond the laboratory, including restoring or controlling dysfunctional neural activity. It does not provide a direct head-to-head trial against drugs or electrical stimulation, so comparisons here reflect established differences between these methods rather than findings from Barik’s experiments.

Neurons are specialised cells that communicate information through the nervous system. They use electrical changes within a cell and chemical messengers between cells. Together, these signals carry information from the body into the spinal cord and brain, where it is processed as sensations such as pain.

For pain, signals linked to injury can travel through connected pathways. The brain then interprets and shapes them, so the experience is influenced by more than the original injury. The article shows this through stress, which altered activity in a brain and spinal-cord circuit and changed pain processing. It also describes a pathway linking pain with its emotional impact after chemotherapy.

Optogenetics gives researchers a way to test these circuits precisely. By switching selected neurons on or off with light, Barik’s team can observe changes in pain or scratching. The article focuses on mouse studies and does not provide a full biology lesson on every neuronal signal, but it shows why these cells and connections matter.